Clinical trial
Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat), Randomized, Parallel-controlled, Multi-center Clinical Study
NCT01082835 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat), Randomized, Parallel-controlled, Multi-center Clinical Study
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2010
- Completion date
- August 31, 2010
- Enrollment
- 240 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.